Asunto(s)
Adenocarcinoma/diagnóstico , Adenocarcinoma/cirugía , Colectomía/métodos , Neoplasias del Colon Sigmoide/patología , Anciano , Biopsia/métodos , Colonoscopía/métodos , Heces/química , Femenino , Humanos , Inmunohistoquímica/métodos , Invasividad Neoplásica/patología , Resultado del TratamientoAsunto(s)
Prolapso Rectal , Humanos , Prolapso Rectal/cirugía , Recto/cirugía , Resultado del TratamientoRESUMEN
OBJECTIVE: In this article, we present the first 100 gynaecological robotic surgeries in Klaipeda University Hospital, Klaipeda, Lithuania. STUDY DESIGN: A prospective analysis was performed of 100 women age range 22-82, on average 52 years. Patients underwent various robotic gynaecological operations, 61 (61 %) procedures were robotic total hysterectomy with bilateral salpingo-oophorectomy. RESULTS: Duration of the surgery varied from 30 min to 185 min, on average 99 ± 33 min. Of all 25 (25 %) patients had operations in the past. Most operations (72 %) were performed for benign diseases and 28 % of the patients were operated for various types of gynaecological malignancies. All cancer surgeries were radical (R0). In-hospital stay was on average 4 ± 2.3 days, range 1-14 days. There were six (6%) conversions: one to laparoscopy and five to open. Three (3%) complications occurred during 30 days after surgery, one demanded surgery (Clavien-Dindo II-IIIb). There was no mortality in this patient population. CONCLUSION: Our early experience with different types of robotic gynaecological surgeries allows us to state that Senhance® robotic system is feasible and safe in gynaecology.
